PubMed · 2005 · 76 citations · 24 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyNeurotoxicologyDrug-induced NeurotoxicityNeurochemical PharmacologyNeuroprotectionNeuroprotective PharmacologyPeripheral Neuropathy ManagementCarnitine SupplementationDrug-induced Peripheral NeuropathyInterferenceNeurotoxicityOxaliplatin-based TherapyPeripheral Neuropathy Models
BACKGROUND: Oxaliplatin (OHP) is severely neurotoxic and induces the onset of a disabling sensory peripheral neuropathy. Acetyl-L-carnitine (ALC), a natural compound with neuroprotective action, was tested to determine whether it plays a protective role in OHP-induced neuropathy. MATERIALS AND METHODS: Peripheral neuropathy was induced in Wistar rats, and the effect of OHP alone or in combination with ALC was assessed, using behavioral and neurophysiological methods. Moreover, ALC interference on OHP antitumor activity was investigated using several in vitro and in vivo models. RESULTS: ALC-co-treatment reduced the neurotoxicity of OHP when it was coadministered. Furthermore, the administration-of OHP, once OHP-induced neuropathy was established, significantly mitigated its severity. Finally, experiments in different tumor systems indicated that ALC does not interfere with the antitumor effects of OHP. CONCLUSION: ALC is effective in the prevention and treatment of chronic OHP-induced peripheral neurotoxicity in an experimental rat model.
24
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10
Sylvie Giacchetti, B Perpoint, Rachid Zidani et al. · Journal of Clinical Oncology · 2000 · 1.4K citations
Medicine, Oncology, Pharmacology +14
D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology · 1996 · 434 citations · Full text
Medicine, Oncology, Pharmacotherapy +13